Skip to Main Content

Getting the right drug to the right place at the right time has been the leading principle of precision medicine, guided by GPS-like genomic advances to engineer targeted therapies. New research from the Whitehead Institute suggests more traditional chemotherapy drugs could also be fine-tuned to hit smaller targets within cells, possibly boosting their efficacy.

Cells contain organelles such as mitochondria, which churn out energy, and ribosomes, which manufacture proteins, but there are also as many as 20 other complex compartments in the nucleus that lack membranes but carry out cellular duties. Proteins cluster within these droplets, called condensates. 

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!